Try

Kewaunee Scientific Corporation Common Stock

KEQUUnited States

6 filed reports · 311 financial concepts · 0 earnings calls · 0 media appearances

Filed reports

6 reports · Apr 2025 to Jul 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 1 operating metrics, 18 commentary passages.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR41,151Jul 2025 to Jul 2026
Annual · 10-KSEC EDGAR21,116Apr 2025 to Apr 2026

Documents

PeriodTypePeriod endPublishedFactsSource
FY2027 Q110-QJul 31, 2026Sep 11, 2026412Open
FY202610-KApr 30, 2026Jun 26, 2026676Open
FY2026 Q310-QJan 31, 2026Mar 13, 2026282Open
FY2026 Q210-QOct 31, 2025Dec 12, 2025251Open
FY2026 Q110-QJul 31, 2025Sep 12, 2025206Open
FY202510-KApr 30, 2025Jul 2, 2025440Open

Financial data

311 concepts · 2,267 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial300 concepts · 2,022 facts · Apr 2024 to Jul 2026

  • Thereafter20 · Apr 2025 to Jul 2026
  • Number of non-qualified compensation plans maintained14 · Apr 2024 to Jul 2026
  • Assets13 · Apr 2024 to Jul 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents13 · Apr 2024 to Jul 2026
  • Stockholders equity (US GAAP)13 · Apr 2024 to Jul 2026
  • 203012 · Apr 2025 to Jul 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect12 · Apr 2024 to Jul 2026
  • Comprehensive income net of tax12 · Apr 2024 to Jul 2026
  • Comprehensive income net of tax attributable to noncontrolling interest12 · Apr 2024 to Jul 2026
  • Comprehensive income net of tax including portion attributable to noncontrolling interest12 · Apr 2024 to Jul 2026
  • Cost of goods and services sold (US GAAP)12 · Apr 2024 to Jul 2026
  • Depreciation12 · Apr 2024 to Jul 2026
  • Depreciation depletion and amortization12 · Apr 2024 to Jul 2026
  • Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents12 · Apr 2024 to Jul 2026
  • Finance lease principal payments12 · Apr 2024 to Jul 2026
  • Gross profit (US GAAP)12 · Apr 2024 to Jul 2026
  • Income tax expense benefit12 · Apr 2024 to Jul 2026
  • Increase decrease in accounts payable and accrued liabilities12 · Apr 2024 to Jul 2026
  • Increase decrease in accounts receivable12 · Apr 2024 to Jul 2026
  • Increase decrease in inventories12 · Apr 2024 to Jul 2026
  • Interest expense nonoperating12 · Apr 2024 to Jul 2026
  • Interest expense on financing liability12 · Apr 2024 to Jul 2026
  • Interest paid net12 · Apr 2024 to Jul 2026
  • Intersegment Eliminations12 · Apr 2024 to Jul 2026

Segment9 concepts · 232 facts · Apr 2024 to Jul 2026

  • Revenue52 · Apr 2024 to Jul 2026
  • Depreciation depletion and amortization26 · Apr 2024 to Jul 2026
  • Income tax expense benefit26 · Apr 2024 to Jul 2026
  • Interest expense nonoperating26 · Apr 2024 to Jul 2026
  • Net income loss26 · Apr 2024 to Jul 2026
  • Net income loss attributable to noncontrolling interest26 · Apr 2024 to Jul 2026
  • Income loss from continuing operations before income taxes extraordinary items noncontrolling interest24 · Apr 2024 to Jul 2026
  • Payments to acquire productive assets18 · Apr 2024 to Jan 2026
  • Segment expenditure addition to long lived assets8 · Apr 2025 to Jul 2026

Geography1 concepts · 12 facts · Apr 2024 to Jul 2026

  • Revenue12 · Apr 2024 to Jul 2026

KPI1 concepts · 1 facts · Jul 2026

  • Backlog Value1 · Jul 2026

Segments

244 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments3 members · 232 facts

  • International Operations116 · Apr 2024 to Jul 2026
  • Domestic Operations80 · Apr 2024 to Jan 2026
  • Laboratory Products Group LPG36 · Apr 2025 to Jul 2026

Statement geographical1 member · 12 facts

  • Non Us12 · Apr 2024 to Jul 2026

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary13 claims from 1 reports · Jul 2026
  • Management discussion (MD&A) commentary18 claims from 1 reports · Jul 2026

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Kewaunee Scientific Corporation Common Stock (KEQU) data · FactIQ